Exchange: NYSE·Updated 07:31 PM EDT
A logo

A Agilent Technologies Inc.

$172.97
$2.58
(1.47%)
Today
Closed $172.97
$0.00
(0.00%)
After Hours
EarningsNov 25
Mkt Cap$48.77B
Vol2.9M

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
44

Bearish Sentiment

How do you feel about A?

RenkoTradingSystem
$A A (Weekly & 195-Min Renko) System Status: GO (2nd Green Brick Confirmed) Setup Trigger (195-Min Renko) 2nd Green Brick Confirmed: Printed cleanly at $171.27, holding above PSAR support ($166.08) and 20-EMA ($165.09). StochRSI: Hooking upward out of oversold territory (0.301), signaling fresh momentum expansion. Extension Filter: Price is safely within range at ~3.7% above the 195-min 20-EMA. Higher-Timeframe Support (Weekly) Weekly RSI(14): 69.02, reflecting robust long-term buying pressure without being overbought. Macro Structure: SCTR sits at an elite 95.0. Price cleanly holds above rising 10-EMA ($160.18) and 20-EMA ($150.34) with weekly Renko back in green. The Takeaway: Agilent satisfies all primary system criteria for a high-probability long entry. Clear runway to earnings on November 25, 2026. Execution Checklist Entry: Buy zone ~$171.27–$172.50 Hard Stop Loss: $166.00 (below 195-min PSAR support) Invalidation: Close position if 195-min red brick prints below $166.08
1
RenkoTradingSystem
$A Two Green Bricks on the 195-Minute 1% Renko Chart. The only thing stopping me from going long is the Weekly 1% Renko chart which has a Red Brick. It will take a +2.04% ($3.43) move higher to turn the Weekly Red Brick to a Green Brick. Weekly RSI Analysis Current Reading: RSI 68.54 Health Check: PASS. Under the system rules a RSI of 68.54 sits in the optimal trend expansion zone. It indicates strong bullish momentum without being in extreme overbought territory (>80). A's Industry (Medical Equipment) just broke out of a month long consolidation.
Trading_Analytics_
$A — Agilent 📈 This has already been a monster swing for me — up 200%+ on the position, and I’m still looking for more upside. The monthly chart is showing a multi-year bullish pennant/large consolidation beneath a descending resistance line. Price has now pushed decisively through that long-term trendline, which is exactly the type of higher-timeframe breakout I like to see. The recent monthly strength suggests the structure may finally be transitioning out of consolidation and into its next expansion phase. I’ve already taken plenty out of this trade, so now I’m watching to see whether $A can hold above the breakout area and turn that old resistance into support. If it does, I believe there could still be substantial upside left in this move. 200%+ and still riding. 🎯📈 Not financial advice — just sharing the setup I’m trading.
FiveSigma
$A Stock 1 / 100 [Doing a technical analysis marathon, my followers will appreciate as this is desperately needed] Agilent made a new ATH - as long as it doesn't retreat in a very bearish like manner (sharp red candlesticks down), I believe it tops around $250 - $260 early next year. Monthly RSI is going vertical. This is extremely bullish and not bearish in the slightest. I believe far OTM calls out here work best
Orapronobis
$A nice short scalp today…will be looking for another one …on watch … overall trend is bullish imo
SICmunduss
$A U.S. All Stars Conference: Agilent Technologies – Key Takeaways from the CEO & CFO interview A few points that stood out: • LC replacement cycle: still <50% through the cycle, with ~7–8 years overall. Management sees **+200–300bps** potential growth contribution. • GC:replacement cycle is earlier, around 25% through, with another ~100bps growth opportunity. • Service & consumables:~70% of service revenue is under 3-year contracts. A growing installed base should support recurring revenue and margins. • China: strong recovery across pharma, food and advanced materials. Management sees **mid/high-single-digit long-term growth. • CDMO:+30% growth in Q3. Train C comes online in spring 2027, with ~75% already booked. Train C + D could ultimately add ~$300M of revenue vs. today. • Reshoring: ~$1BN opportunity, with ~$300M targeted by 2030. Orders are now starting to come through.
dustlesspuma
🟢 $A 165C Oct 16 💰 $101,100 premium 💵 $3.8/contract 📊 2.6x Vol/OI 📍 Spot $161.75 💰 Large premium | 🚨 Repeat sweep 🌊 Dark Flow | Options Flow

Advertisement|Remove ads.